よむ、つかう、まなぶ。
【別添】新型コロナウイルス感染症（COVID-19）診療の手引き別冊罹患後症状のマネジメント（第３.０版） (13 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00402.html |
| 出典情報 | 新型コロナウイルス感染症（COVID-19）診療の手引き別冊罹患後症状のマネジメント（第3.0版）（10／20）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症（COVID-19） 診療の手引き
別冊
罹患後症状のマネジメント・第 3.0 版 ●１ 罹患後症状
◆引用・参考文献◆
・厚生労働省特別研究事業．令和 4 年度 COVID-19 感染者の健康と回復に関するコホートの主な結果 ：住民調査 : 八尾市，品
川区，札幌市（門田班）．2023.9.19.
・厚生労働省特別研究事業．COVID-19 感染回復後の後遺障害の実態調査（横山班）
，および新型コロナウイルス感染症
（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究（福永班）
．第 86 回新型コロナウイルス感染症対策
アドバイザリーボード資料．2022.6.1.
・厚生労働省特別研究事業．COVID-19 後遺障害に関する実態調査（中間 / 最終報告）
．第 39 回新型コロナウイルス感染症
対策アドバイザリーボード資料．2021.6.16．
・国立国際研究医療センター COVID-19 レジストリー研究．東京 i CDC 専門家ボード 第 31 回東京都新型コロナウイルス感
染症モニタリング会議資料．2021.2.4．
・Antonelli, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. Jun
18;399(10343) : 2263-2264, 2022.
・Ballouz T, et al. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior
vaccination: Pooled analysis of two population-based cohorts. Plos one 18(2): e0281429, 2023.
・Ballouz T, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population
based, longitudinal cohort study. BMJ 381, 2023.
・Buonsenso D, et al. Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants.
Acta Paediatr. 112(6):1284-6, 2023.
・Byambasuren O, et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ medicine 2 : 1, 2023.
・Canas S, et al. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective
longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
The Lancet Digital Health, 2023.
・Fernández-de-Las-Peñas, et al. Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among
Hospitalized vs Nonhospitalized Patients. JAMA network open 5(11): e2242106-e2242106, 2022.
・Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic
review. JAMA Netw Open 4：e2128568, 2021.
・Han Q, et al. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up
studies on post-COVID symptoms. Pathogens 2022, 11(2), 269.
・Huang L.1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. Aug 28;
398(10302): 747-758,2021.
・Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal
cohort study. Lancet Respir Med. Sep;10(9):863-876, 2022.
・Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls
(LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 6(4):240-8, 2022.
・Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched
controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health.
6(9):614-23, 2022.
・Kompaniyets L, et al. Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United
States, March 1, 2020-January 31, 2022. MMWR-Morbidity and Mortality Wkly Rep,. 71(31):993-9, 2022.
・Molteni E, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARSCoV-2. Lancet Child Adolesc Health. 5(10):708-18, 2021.
・Morello R, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
EClinicalMedicine. 59:101961, 2023.
・Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing longCOVID symptoms: A systematic review. EClinicalMedicine. Aug 27 ; 53:101624, 2022.
・Pellegrino R,et al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J
Pediatr. 181(12):3995-4009, 2022.
・Peñas CF, et al. Post–COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs
nonhospitalized patients. JAMA Netw Open. 2022;5(11):e2242106.
・Rao S, et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and
Adolescents. JAMA Pediatr. 176(10):1000-9, 2022.
・Roessler M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort
study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 19(11):e1004122, 2022.
・Shaffer L. Lots of long COVID treatment leads, but few are proven. Proc Natl Acad Sci U S A. Sep 6;119(36):
e2213524119, 2022.
・Stephenson T, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among
adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 6(4):230-9, 2022.
・Subramanian, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. Aug;28(8):
1706-1714, 2022.
・US CDC. Post-COVID conditions: Information for healthcare providers. Updated July 9, 2021.
・Wahlgren C,et al.Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort
study. The Lancet Regional Health - Europe 2023;28: 100595.
・Watanabe A, et al. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review
and meta-analysis. Vaccine, 2023.
12
別冊
罹患後症状のマネジメント・第 3.0 版 ●１ 罹患後症状
◆引用・参考文献◆
・厚生労働省特別研究事業．令和 4 年度 COVID-19 感染者の健康と回復に関するコホートの主な結果 ：住民調査 : 八尾市，品
川区，札幌市（門田班）．2023.9.19.
・厚生労働省特別研究事業．COVID-19 感染回復後の後遺障害の実態調査（横山班）
，および新型コロナウイルス感染症
（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究（福永班）
．第 86 回新型コロナウイルス感染症対策
アドバイザリーボード資料．2022.6.1.
・厚生労働省特別研究事業．COVID-19 後遺障害に関する実態調査（中間 / 最終報告）
．第 39 回新型コロナウイルス感染症
対策アドバイザリーボード資料．2021.6.16．
・国立国際研究医療センター COVID-19 レジストリー研究．東京 i CDC 専門家ボード 第 31 回東京都新型コロナウイルス感
染症モニタリング会議資料．2021.2.4．
・Antonelli, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. Jun
18;399(10343) : 2263-2264, 2022.
・Ballouz T, et al. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior
vaccination: Pooled analysis of two population-based cohorts. Plos one 18(2): e0281429, 2023.
・Ballouz T, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population
based, longitudinal cohort study. BMJ 381, 2023.
・Buonsenso D, et al. Risk of long Covid in children infected with Omicron or pre-Omicron SARS-CoV-2 variants.
Acta Paediatr. 112(6):1284-6, 2023.
・Byambasuren O, et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ medicine 2 : 1, 2023.
・Canas S, et al. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective
longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations.
The Lancet Digital Health, 2023.
・Fernández-de-Las-Peñas, et al. Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among
Hospitalized vs Nonhospitalized Patients. JAMA network open 5(11): e2242106-e2242106, 2022.
・Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic
review. JAMA Netw Open 4：e2128568, 2021.
・Han Q, et al. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up
studies on post-COVID symptoms. Pathogens 2022, 11(2), 269.
・Huang L.1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. Aug 28;
398(10302): 747-758,2021.
・Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal
cohort study. Lancet Respir Med. Sep;10(9):863-876, 2022.
・Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls
(LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 6(4):240-8, 2022.
・Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched
controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health.
6(9):614-23, 2022.
・Kompaniyets L, et al. Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United
States, March 1, 2020-January 31, 2022. MMWR-Morbidity and Mortality Wkly Rep,. 71(31):993-9, 2022.
・Molteni E, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARSCoV-2. Lancet Child Adolesc Health. 5(10):708-18, 2021.
・Morello R, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
EClinicalMedicine. 59:101961, 2023.
・Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing longCOVID symptoms: A systematic review. EClinicalMedicine. Aug 27 ; 53:101624, 2022.
・Pellegrino R,et al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J
Pediatr. 181(12):3995-4009, 2022.
・Peñas CF, et al. Post–COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs
nonhospitalized patients. JAMA Netw Open. 2022;5(11):e2242106.
・Rao S, et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and
Adolescents. JAMA Pediatr. 176(10):1000-9, 2022.
・Roessler M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort
study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 19(11):e1004122, 2022.
・Shaffer L. Lots of long COVID treatment leads, but few are proven. Proc Natl Acad Sci U S A. Sep 6;119(36):
e2213524119, 2022.
・Stephenson T, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among
adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 6(4):230-9, 2022.
・Subramanian, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. Aug;28(8):
1706-1714, 2022.
・US CDC. Post-COVID conditions: Information for healthcare providers. Updated July 9, 2021.
・Wahlgren C,et al.Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort
study. The Lancet Regional Health - Europe 2023;28: 100595.
・Watanabe A, et al. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review
and meta-analysis. Vaccine, 2023.
12